<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr91-0300060520949077">
 <label>91</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ko</surname>
    <given-names>WC</given-names>
   </name>
   <name>
    <surname>Rolain</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>NY</given-names>
   </name>
  </person-group>, 
  <etal>etÂ al</etal>
  <article-title>Arguments in favour of remdesivir for treating SARS-CoV-2 infections</article-title>. 
  <source>Int J Antimicrob Agents</source>
  <year>2020</year>; 
  <volume>55</volume>: 
  <fpage>105933</fpage>.
  <pub-id pub-id-type="pmid">32147516</pub-id>
 </mixed-citation>
</ref>
